# Bivalirudin

NDC: 70511-142
Generic name: Bivalirudin
Labeler / Manufacturer: MAIA Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20240527

FDA application: NDA211215

## Active ingredients

- BIVALIRUDIN: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70511-142"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70511-142
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c727199d-f4cd-4658-8fdf-568590beface